Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:664-670
doi: 10.1161/01.CIR.0000112580.31594.F9
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fogarty, J. A.
Right arrow Articles by Parker, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogarty, J. A.
Right arrow Articles by Parker, J. L.

(Circulation. 2004;109:664-670.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Exercise Training Enhances Vasodilation Responses to Vascular Endothelial Growth Factor in Porcine Coronary Arterioles Exposed to Chronic Coronary Occlusion

Jennifer A. Fogarty, PhD; Judy M. Muller-Delp, PhD; Michael D. Delp, PhD; Mildred L. Mattox, BS; M. Harold Laughlin, PhD; Janet L. Parker, PhD

From the Cardiovascular Research Institute and Department of Medical Physiology, Texas A&M University System Health Science Center (J.A.F., M.L.M., J.L.P.), and Department of Health and Kinesiology (J.M.M.-D., M.D.D.), Texas A&M University, College Station, Tex, and Dalton Cardiovascular Research Center and Departments of Physiology and Biomedical Sciences, University of Missouri, Columbia (M.H.L.).

Correspondence to Janet L. Parker, Cardiovascular Research Institute and Department of Medical Physiology, TAMUS HSC MS 1114, College Station, TX 77843-1114. E-mail jlp{at}tamu.edu

Received December 30, 2002; de novo received May 9, 2003; revision received October 3, 2003; accepted October 6, 2003.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions and Implications
down arrowReferences
 
Background— Chronic coronary occlusion (CCO) impairs endothelial function of distal collateral–dependent microvasculature; however, long-term exercise training (EX) seems to improve endothelial dysfunction. We hypothesized that EX enhances vasodilation responses to vascular endothelial growth factor (VEGF165), mediated via nitric oxide (NO), in arterioles exposed to CCO.

Methods and Results— The proximal left circumflex coronary artery (LCx) of female Yucatan miniswine was surgically instrumented with an ameroid occluder to induce CCO; 8 weeks after surgery, animals were randomized into 14-week sedentary (SED) or EX (treadmill; 5 d/wk) protocols. Coronary arterioles ({approx}100 µm in diameter) were isolated from collateral-dependent (LCx) and nonoccluded (left anterior descending; LAD) perfused myocardium of SED and EX animals. Vasodilation was assessed by videomicroscopy and MacLab data acquisition. Responses to VEGF165 were unaffected by EX in nonoccluded LAD arterioles; in contrast, EX markedly enhanced VEGF165-induced vasodilation of collateral-dependent LCx arterioles (P<0.05; EX versus SED). Furthermore, VEGF165-induced vasodilation of EX LCx arterioles exceeded that of EX or SED LAD arterioles (P<0.05). Enhanced vasodilation of EX LCx arterioles was abolished by inhibition of NO synthase and tyrosine kinase activity. Combined inhibition of NO synthase and cyclooxygenase decreased VEGF165-induced vasodilation of all vessels.

Conclusions— EX enhances VEGF165-induced vasodilation in arterioles distal to CCO; EX effects seem to be mediated through increases in NO.


Key Words: microcirculation • nitric oxide • occlusion • coronary disease • collateral circulation


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions and Implications
down arrowReferences
 
Chronic coronary occlusion (CCO) often results in ischemia and dysfunction of distal myocardium during increased cardiac workload, partly because of limited development of collateral circulation.1–4 CCO creates a proangiogenic environment that is dependent on the presence of growth factors and appropriate receptors.1,5 Indeed, increased myocardial release of vascular endothelial growth factor (VEGF) has been demonstrated after coronary artery occlusion.6 Furthermore, a significant body of evidence indicates that impaired endothelial function and altered vasomotor responsiveness of collateral-dependent vasculature contribute to abnormal regulation of coronary tone distal to CCO.7–10 For instance, impaired endothelium-dependent nitric oxide (NO)–mediated vasodilation persists in the microvasculature distal to the occlusion7,8,10 and is associated with CCO-induced reduction in endothelial cell NO synthase (ecNOS) mRNA in coronary arterioles.10 Because NO plays pivotal roles in key endothelial signaling pathways, altered NO-dependent functions may have important consequences on vasomotor and angiogenic responses in the diseased heart.

Interestingly, long-term exercise training (EX) has been shown to ameliorate endothelial dysfunction via undefined mechanisms.10–12 In normal pigs, ecNOS mRNA of coronary arterioles is upregulated by EX.13 Griffin et al10 recently reported that impaired microvascular responsiveness to bradykinin in porcine CCO is reversed by EX and that the occlusion-related reduction of ecNOS mRNA in arterioles is prevented or reversed by EX. These results indicate that EX-induced increases in production and/or stabilization of NO may contribute to improved coronary microvascular function in the CCO model.10

In addition, EX increases VEGF protein expression in normally perfused muscle14 and increases VEGF mRNA in a model of femoral ligation.15 Exercise-induced increases in VEGF mRNA and protein in muscle have also been demonstrated in heart failure patients.16 Importantly, because the effects of VEGF on vasodilation, angiogenesis, and collateral development are believed to involve NO production,17–19 we hypothesized that EX enhances VEGF-mediated vasodilation in collateral-dependent coronary arterioles and that enhanced VEGF responses are mediated by the effects of NOS and NO production.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowConclusions and Implications
down arrowReferences
 
Porcine Model of CCO and Collateral Development
CCO and collateral development were induced in adult female Yucatan swine (Sinclair Research Farm, Columbia, Mo) as previously described.7,10–12,20 Briefly, a left lateral thoracotomy was performed and an ameroid occluder (Research Instruments SW) placed around the proximal left circumflex coronary artery (LCx). This model has a >95% success rate and results in minimal infarction (<7% area at risk) because of gradual occlusion.1,20,21 In the present study, 75 pigs were instrumented; none died during surgery or in the immediate perioperative period, 12 died before protocol assignment, and 1 died during exercise training. Protocols were approved by the Texas A&M University Institutional Animal Care and Use Committee and conformed to the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals (DHHS Publication NIH 85-23, Office of Science and Health Reports, Bethesda, Md).

Training Procedures
After 8 weeks of postoperative recovery, pigs were randomly assigned to sedentary (SED; n=29) or exercise training (EX; n=33) groups. Animals were fed once daily and allowed water ad libitum. SED animals remained confined to pens. EX animals were exposed to a 14-week treadmill program used extensively by this laboratory and others.10–12,22

Isolated Microvessel Preparation
After completion of the protocols, animals were anesthetized, the heart was removed, and transmural tissue samples were dissected from collateral-dependent myocardium and myocardium perfused by the unoccluded left anterior descending (LAD) coronary artery.

Subepicardial arteriolar branches (<150-µm ID; 0.6 to 1 mm axial length) were dissected, and cannulation was performed as described previously by Muller-Delp et al.23 Briefly, arterioles were cannulated in a Lucite chamber with micropipettes, secured with suture, transferred to an inverted microscope (Olympus IX70), and pressurized. Vessels were visualized and assessed via videocamera (Panasonic BP310), CCTV monitor (Panasonic), video micrometer (Microcirculation Research Institute, TAMUSHSC), and a data-acquisition system (Macintosh/MacLab). Vessels were warmed to 37°C and equilibrated for 60 minutes at a static intraluminal pressure of 40 mm Hg.

Training Efficacy/Oxidative Enzyme Capacity
Training efficacy was determined via comparison of skeletal muscle citrate synthase activities11,12,22 and heart-to–body weight ratios between SED and EX animals. Samples of deltoid and triceps brachii were immediately frozen in liquid N2 and stored at -70°C. Citrate synthase activity was determined from whole-muscle homogenate and spectrophotometry.24

Experimental Protocols
Functional assessment to agonist (±inhibitors) was conducted at static pressure with no flow. Arterioles were assessed for generation of spontaneous tone sufficient for vasodilation studies, and if inadequate, endothelin-1 was administered abluminally. Once diameter had stabilized, concentration-response relationships to adenosine (10-10 to 10-4 mol/L) and VEGF165 (10-14 to 10-9 mol/L) (R&D Systems) were determined by cumulative additions.

Freshly prepared arterioles were used to evaluate responses to VEGF165 in the presence of selective inhibitors. Arterioles underwent a 20-minute preincubation with inhibitor and subsequent treatment with endothelin-1 to achieve adequate tone. NG-Monomethyl-L-arginine (L-NMMA; 10 µmol/L; Calbiochem) was used to inhibit NOS, and indomethacin (10 µmol/L) was used to block cyclooxygenase (COX)–mediated prostanoid release. Piceatannol (10 µmol/L) was used to inhibit tyrosine kinase activity. At the conclusion of the experiment, nitroprusside (100 µmol/L) was used to determine maximal vessel diameter.

Solutions and Drugs
Chemicals were obtained from Sigma, except as stated. Physiological saline solution (PSS) contained (in mmol/L) NaCl 145, KCl 4.7, CaCl2 2.0, MgSO4 1.17, NaH2PO4 1.2, glucose 5.0, pyruvate 2.0, EDTA 0.02, and MOPS buffer 3.0. All solutions were adjusted to pH 7.4. VEGF165 was prepared in PSS with albumin (USB/Amersham). L-NMMA and indomethacin were prepared in PSS. Piceatannol was dissolved in DMSO as a stock solution, and dilutions were in PSS.

Data Analysis
Citrate synthase activity of skeletal muscle and heart-to–body weight ratios were compared by Student’s unpaired t test. Vasodilator responses were expressed as percentage of maximal diameter. Concentration-response curves were compared by 2-way ANOVA for repeated measures with Fisher’s test for least significant difference (LSD). For all analyses, significance is defined as a value of P<=0.05. Data are represented as mean±SEM. Animal numbers are in parentheses.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowConclusions and Implications
down arrowReferences
 
Training Efficacy
Citrate synthase activity was significantly increased in skeletal muscle samples from EX versus SED animals (Table 1). The heart-to–body weight ratio of EX animals was significantly higher than that of SED animals (P<0.001; EX versus SED).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Exercise Training Effects

Vessel Characteristics
Lumen diameter, percent preconstriction, and concentration of endothelin-1 used were similar between LAD and LCx arterioles from EX and SED animals (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Characteristics of Porcine Arterioles Isolated From Hearts Exposed to CCO

Vasodilation Response to VEGF165
Collateral-dependent LCx arterioles from EX animals displayed significantly enhanced VEGF165-induced vasodilation compared with LCx arterioles from SED animals and nonoccluded LAD arterioles from SED and EX animals (P<0.05; Figure 1). VEGF165 produced similar concentration-dependent vasodilation of SED and EX LAD arterioles. SED LCx arterioles did not display an attenuated VEGF165-induced vasodilation, as demonstrated by comparison with SED LAD. Both occlusion and EX seem to be necessary to produce an enhanced vasodilation to VEGF165, as shown in Figure 1. On removal of VEGF, tone in these arterioles recovered to levels not different from initial tone (data not shown).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1. VEGF165-induced vasodilation of coronary arterioles isolated from collateral-dependent (LCx) and nonoccluded (LAD) myocardium. EX LCx exhibits significantly enhanced VEGF165-induced vasodilation compared with SED LCx or EX and SED LAD (*P<0.05). LAD arterioles from SED and EX animals responded similarly to VEGF165.

Role of NO in EX-Induced, Enhanced Response to VEGF165
NOS inhibition (L-NMMA; 10 µmol/L) decreased the maximal VEGF165-induced dilation but did not significantly reduce the overall vasodilation of EX LAD arterioles. In addition, LAD arterioles from EX and SED animals responded similarly to VEGF165 in the presence of L-NMMA (Figure 2). L-NMMA significantly reduced vasodilation of EX LCx arterioles to VEGF165, indicating a potential role for enhanced NO production after EX, but did not significantly affect SED LCx arterioles (Figure 2). Importantly, L-NMMA abolished the enhanced vasodilation of EX LCx arterioles, as demonstrated by comparison of EX and SED LCx. Substantial VEGF165-induced vasodilation remained after NOS inhibition in all arterioles.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. VEGF165-induced vasodilation of arterioles with and without NOS inhibition (L-NMMA; 10 µmol/L). NOS inhibition minimally affected EX and SED LAD and SED LCx arterioles. EX LCx vasodilation was significantly inhibited by L-NMMA (*P<0.05). Enhanced vasodilation displayed by EX LCx (Figure 1) was abolished, and no difference was observed between SED and EX LCx in presence of L-NMMA.

Role of Prostanoid Vasodilators in VEGF165-Induced Dilation
Combined inhibition of NOS (L-NMMA; 10 µmol/L) and COX (indomethacin; 10 µmol/L) did significantly inhibit VEGF165-induced vasodilation of EX LAD arterioles. However, dual blockade did not significantly inhibit response of SED LAD arterioles (Figure 3). Vasodilation of SED and EX LCx arterioles to VEGF165 was significantly reduced by inhibition of NOS and COX; EX LCx arterioles were more profoundly affected (Figure 3). Combined inhibition did not abolish the vasodilation response to VEGF165.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 3. VEGF165-induced vasodilation of arterioles after combined NOS (L-NMMA; 10 µmol/L) and COX (indomethacin; 10 µmol/L) inhibition. Vasodilation of EX LAD (*P<0.05) but not SED LAD was significantly reduced by inhibition of NOS and COX. Last 2 doses of SED LAD concentration-response curve were significantly different (*P<0.05, unprotected Fisher’s LSD; control vs combined inhibition); however, overall response curves were not. Dual inhibition significantly reduced vasodilation of SED LCx (*P<0.05) and EX LCx (*P<0.01).

Role of Tyrosine Kinase Activity in VEGF165-Induced Dilation
Vasodilation of SED LAD and LCX arterioles and that of EX LAD arterioles were similarly diminished by tyrosine kinase inhibition (piceatannol; 10 µmol/L) (Figure 4). VEGF165-induced vasodilation of SED LCx arterioles seemed to be unaffected by piceatannol (Figure 4). Importantly, vasodilation of EX LCx arterioles was significantly diminished by piceatannol; indeed, vasodilation was no longer enhanced (EX versus SED).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 4. VEGF165-induced vasodilation of arterioles with and without tyrosine kinase inhibition (piceatannol; 10 µmol/L). EX LCx vasodilation was significantly reduced by piceatannol (*P<0.01; right). Indeed, piceatannol abolished training effect shown in Figure 1. SED and EX LAD concentration-response curves were minimally affected by tyrosine kinase inhibition; only last 3 doses of each concentration-response curve were significantly reduced (*P<0.05, unprotected Fisher’s LSD; control vs piceatannol).

Vascular Smooth Muscle Responses
Sodium nitroprusside (100 µmol/L) was used to establish maximal diameter and vascular smooth muscle–dependent vasodilation. Responses were not different between vessels (not shown). In addition, adenosine produced responses that were not different in LAD and LCx arterioles from SED and EX animals (Figure 5) and were unaffected by L-NMMA (not shown).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 5. Adenosine-induced vasodilation of coronary arterioles from SED and EX animals exposed to CCO. Responses of coronary arterioles to adenosine were unaffected by exercise training and/or CCO.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowConclusions and Implications
down arrowReferences
 
In the present study, we used a porcine model of CCO to document, for the first time, that long-term exercise training enhances vasodilation responses of collateral-dependent LCx arterioles to VEGF165. Furthermore, the enhanced response of LCx arterioles from EX animals seems to be attributable to increased synthesis/release of NO. In addition, we report that NO, prostanoid vasodilators, and potentially other vasoactive substances are released by porcine coronary arterioles in response to VEGF165. Data from this study imply a beneficial role for chronic exercise training in CCO, with respect to enhanced endothelial function and coronary/myocardial responses to VEGF, as well as potential interactive effects of EX and CCO on optimization of collateralization and myocardial perfusion.

Vasodilation to VEGF165
VEGF plays a significant role in angiogenesis and collateral development in coronary and peripheral vascular occlusive diseases.18,19 In the present study, CCO combined with EX resulted in enhanced vasodilation of isolated coronary arterioles to VEGF165. After training, vasodilation of collateral-dependent LCx arterioles exceeded that of LCx arterioles from SED animals and nonoccluded LAD arterioles (SED and EX). We believe that enhanced vasodilation after training in arterioles subjected to CCO may imply an increased role of VEGF165 in ongoing collateral development in our model. Furthermore, previous studies have established that training increases release of VEGF and VEGF receptor mRNA expression in ischemic muscle.15 Taken together, these data imply a synergistic environment in collateral-dependent myocardium of EX animals because of increased VEGF and enhanced microvascular sensitivity to VEGF.

Sellke et al25 reported enhanced responses to VEGF in coronary arterioles of untrained animals exposed to chronic occlusion. Explanations for discrepancies with our findings in SED animals are unclear. However, Sellke et al performed studies 7 to 9 weeks after instrumentation,25 whereas our study assessed function 22 weeks after ameroid placement. Collateral development at 8 weeks in this model provides adequate blood flow in resting myocardium20,21 but insufficient flow during physiological stress.3,20,21 Possibly, at 7 to 9 weeks, collateral development may be more limited than at 22 weeks, inadequately perfusing "resting" myocardium and potentially causing variable ischemic episodes stimulating enhanced VEGF-induced responses under sedentary conditions.26

VEGF165-Induced Vasodilation: Role of NOS and Cyclooxygenase
VEGF upregulates ecNOS expression and protein,27–29 induces production of NO and prostacyclin in endothelial cells,27,30–33 and increases circulating endothelial progenitor cells.34 Exercise training induces increases in ecNOS mRNA in normal porcine hearts,13 prevents reduction in ecNOS mRNA in porcine hearts exposed to CCO,10 and induces VEGF release from ischemic muscle.15 Thus, enhanced VEGF165-induced vasodilation after training may result from several underlying mechanisms, including VEGF receptor upregulation, increased ecNOS activity (via ecNOS mRNA/protein upregulation or enhanced Ca2+ mobilization), and/or enhanced VEGF signal transduction in collateral-dependent arterioles. In addition, we speculate that VEGF-induced increases in circulating endothelial progenitor cells may contribute to beneficial reendothelialization of the microvasculature downstream from occlusion.34 These effects may culminate in improved endothelial function; increased endothelial production of NO, which mediates vasodilation35; increased blood flow; and the angiogenic process.27,30 This explanation is substantiated by NOS inhibition abolishing EX-induced enhanced vasodilation of collateral-dependent arterioles to VEGF165 (Figure 2). Interestingly, NOS inhibition did not significantly affect VEGF165-induced vasodilation of collateral-dependent arterioles from SED animals and minimally affected normally perfused arterioles from SED and EX animals. Therefore, NO may play a greater role in VEGF-mediated vasodilation after training compared with responses observed in SED animals. Also, although lack of NOS blockade by L-NMMA could theoretically contribute to our results in SED LCx arterioles, we believe that this possibility is unlikely. Hein and Kuo36 demonstrated that L-NMMA (10 µmol/L) significantly inhibits agonist-stimulated NO production in porcine coronary arterioles. Furthermore, 10 µmol/L L-NMMA does not affect basal diameter or basal NO release37 measured in isolated arterioles and is without nonspecific smooth muscle effects observed at higher concentrations.38 Nonetheless, our findings prompted experiments to further define the mechanisms by which VEGF165 caused vasodilation in coronary arterioles from our model.

VEGF stimulates production of NO and prostacyclin, which increase vessel permeability, induce endothelial cell proliferation and migration,30,39,40 and cause vasodilation25 and hypotension.35 In agreement, we found that both NO- and COX-mediated vasodilators contribute to VEGF165-induced vasodilation. Combined inhibition of NOS and cyclooxygenase significantly impaired vasodilation of collateral-dependent arterioles from EX and SED animals (Figure 3). However, the combined results of Figures 2 and 3Up indicate that the relative contribution of NO to VEGF relaxation dominates in LCx arterioles from EX animals, whereas COX-mediated vasodilators play an increased role in LAD arterioles from SED and EX animals and LCx arterioles from SED animals. Interestingly, combined inhibition did not completely abolish the VEGF165-induced vasodilation, which suggests that unidentified vasoactive substances may be released in response to VEGF165 and contribute to vasodilation. A prime candidate is endothelial hyperpolarizing factor, although methods to establish its role were not used.

VEGF165-Induced Vasodilation: Role of Tyrosine Kinases
VEGF is believed to confer its major effects via tyrosine kinase receptors.41 Therefore, inhibition of tyrosine kinase activity should abolish VEGF intracellular signaling and production of vasoactive substances. In our preparation, tyrosine kinase inhibition significantly reduced vasodilation of collateral-dependent arterioles from EX animals and abolished the effects of training on VEGF165 response (Figure 4). However, collateral-dependent arterioles from SED animals seemed to be unaffected by piceatannol. Reversal of the training effect strongly implies a role of tyrosine kinase activation in training-induced enhancement of VEGF165-induced vasodilation and NO production. To the best of our knowledge, this is the first report that the effects of exercise training in experimental coronary disease involve alterations in VEGF signaling mechanisms such as tyrosine kinase pathways. Interestingly, tyrosine kinase inhibition did not completely abolish vasodilation to VEGF165. This finding is in agreement with previous reports using porcine coronary arterioles25 and implies that VEGF165 may induce release of vasodilators through signaling cascades other than activation of tyrosine kinases.

Vascular Smooth Muscle Responses
Theoretically, training-induced enhanced vasodilation to VEGF could result from increased responsiveness of coronary microvascular smooth muscle. However, unlike vasodilation to VEGF, smooth muscle responses to nitroprusside10 (an NO donor) and adenosine (present study) in arterioles from EX and SED animals are unaffected by either CCO or training. These studies provide important controls for VEGF responses and indicate that arteriolar smooth muscle responses to NO and adenosine and downstream cGMP/cAMP mechanisms are unaltered and do not contribute to enhanced VEGF relaxation after training.


*    Conclusions and Implications
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Conclusions and Implications
down arrowReferences
 
To the best of our knowledge, this study provides the first evidence that exercise training, in the setting of CCO, elicits enhanced microvascular vasodilation responses to VEGF165. Training-induced effects on VEGF-induced vasodilation seem to involve increased synthesis/release of NO via tyrosine kinase–dependent pathways. These findings are in agreement with reports of enhanced endothelium-dependent, NO-mediated vasodilation to the agonist bradykinin in both normal22 and collateral-dependent10 coronary arterioles after training. In light of recent documentation that CCO-induced decreases in coronary arteriolar ecNOS mRNA levels are prevented/reversed by exercise training,10 these studies are supportive of the concept that exercise training results in an increased vasoregulatory role of NO in coronary microvascular function.

Increased NO production after training implies other beneficial effects of NO present in diseased myocardium, including reduction in platelet adhesion and aggregation, thrombogenicity, and vasospasm, as well as increased angiogenesis and optimized collateralization. We recognize the difficulties of extrapolating these in vitro findings to the intact heart under conditions of varying coronary flow. However, we speculate that these positive effects of exercise training on VEGF/NO responses may potentially contribute to improved perfusion of collateral-dependent myocardium and may be involved in improved myocardial function and enhanced coronary vasodilator reserve of collateral-dependent myocardium observed after long-term exercise in a similar porcine model of CCO.21 Thus, this study further substantiates the beneficial role of exercise training in improving endothelial function and blood flow to the myocardium distal to occlusion. Importantly, these findings also imply endothelium-related mechanisms underlying known beneficial effects of exercise in patients with coronary artery disease as well as reductions in morbidity and mortality associated with improved endothelial function.42,43


*    Acknowledgments
 
These studies were supported by National Institutes of Health grants RO1-HL-452131, PO1-HL-52490, and RO1-HL-64931. The authors greatly appreciate technical contributions made by Ester De Los Santos.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowConclusions and Implications
*References
 

  1. Roth DM, Maruoka Y, Rogers J, et al. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol. 1987; 253: H1279–H1288.[Medline] [Order article via Infotrieve]
  2. Lambert PR, Hess DS, Bache RJ. Effect of exercise on perfusion of collateral-dependent myocardium in dogs with chronic coronary artery occlusion. J Clin Invest. 1977; 59: 1–7.[CrossRef][Medline] [Order article via Infotrieve]
  3. McKirnan MD, Bloor CM. Clinical significance of coronary vascular adaptations to exercise training. Med Sci Sports Exerc. 1994; 26: 1262–1268.[Medline] [Order article via Infotrieve]
  4. Roth DM, McKirnan MD, White FC, Bloor CM. Regional myocardial dysfunction during progressive coronary occlusion in conscious swine. Cardiovasc Pathobiol. 1996; 1: 97–103.
  5. Breisch EA, White FC, Nimmo LE, et al. Exercise-induced cardiac hypertrophy: a correlation of blood flow and microvasculature. J Appl Physiol. 1986; 60: 1259–1267.[Abstract/Free Full Text]
  6. Jingjing L, Srinivasan B, Bian X, et al. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart. Mol Cell Biochem. 2000; 214: 23–30.[CrossRef][Medline] [Order article via Infotrieve]
  7. Sellke FW, Kagaya Y, Johnson RG, et al. Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals. Am J Physiol. 1992; 262: H1669–H1675.[Medline] [Order article via Infotrieve]
  8. Sellke FW, Quillen JE, Brooks LA, et al. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation. 1990; 81: 1938–1947.[Abstract/Free Full Text]
  9. Rapps JA, Sturek M, Jones AW, et al. Altered reactivity of coronary arteries located distal to a chronic occlusion. Am J Physiol. 1997; 273: H1879–H1887.[Medline] [Order article via Infotrieve]
  10. Griffin KL, Woodman CR, Price EM, et al. Endothelium-mediated relaxation of porcine collateral-dependent arterioles is improved by exercise training. Circulation. 2001; 104: 1393–1398.[Abstract/Free Full Text]
  11. Griffin KL, Laughlin MH, Parker JL. Exercise training improves endothelium-mediated vasorelaxation after chronic coronary occlusion. J Appl Physiol. 1999; 87: 1948–1956.[Abstract/Free Full Text]
  12. Heaps CL, Sturek M, Rapps JA, et al. Exercise training restores adenosine-induced relaxation in coronary arteries distal to chronic occlusion. Am J Physiol. 2000; 278: H1984–H1992.
  13. Woodman CR, Muller JM, Laughlin MH, et al. Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs. Am J Physiol. 1997; 273: H2575-H2579.[Medline] [Order article via Infotrieve]
  14. Amaral SL, Papanek PE, Greene AS. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol. 2001; 281: H1163-H1169.
  15. Lloyd PG, Prior BM, Yang HT, et al. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol. 2003; 284: H1668–H1678.
  16. Gustafsson T, Bodin K, Sylven C, et al. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest. 2001; 31: 362–366.[CrossRef][Medline] [Order article via Infotrieve]
  17. Lopez JJ, Laham RJ, Carrozza JP, et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol. 1997; 273: H1317–H1323.[Medline] [Order article via Infotrieve]
  18. Ferrara N, Gerber H-P. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001; 106: 148–156.[CrossRef][Medline] [Order article via Infotrieve]
  19. Matsunaga T, Warltier DC, Weihrauch DW, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation. 2000; 102: 3098–3103.[Abstract/Free Full Text]
  20. White FC, Carroll SM, Magnet A, et al. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992; 71: 1490–1500.[Abstract/Free Full Text]
  21. Roth DM, White FC, Nichols ML, et al. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation. 1990; 82: 1778–1789.[Abstract/Free Full Text]
  22. Muller JM, Myers PR, Laughlin MH. Vasodilator responses of coronary resistance arteries of exercise-trained pigs. Circulation. 1994; 89: 2308–2314.[Abstract/Free Full Text]
  23. Muller-Delp JM, Spier SA, Ramsey MW, et al. Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am J Physiol. 2002; 283: H1662–H1672.
  24. Srere PA. Citrate synthase. Methods Enzymol. 1969; 13: 3–11.[CrossRef]
  25. Sellke FW, Wang SY, Stamler A, et al. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol. 1996; 271: H713–H720.[Medline] [Order article via Infotrieve]
  26. Liu Y, Cox SR, Morita T, et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5' enhancer. Circ Res. 1995; 77: 638–643.[Abstract/Free Full Text]
  27. Hood JD, Meininger CJ, Ziche M, et al. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998; 274: H1054–H1058.[Medline] [Order article via Infotrieve]
  28. Shen B-Q, Lee DY, Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem. 1999; 274: 33057–33063.[Abstract/Free Full Text]
  29. Bouloumié A, Schini-Kerth VB, Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res. 1999; 41: 773–780.[CrossRef][Medline] [Order article via Infotrieve]
  30. Murohara T, Horowitz JR, Silver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998; 97: 99–107.[Abstract/Free Full Text]
  31. Parenti A, Morbidelli L, Cui X-L, et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem. 1998; 273: 4220–4226.[Abstract/Free Full Text]
  32. He H, Venema VJ, Gu X, et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem. 1999; 274: 25130–25135.[Abstract/Free Full Text]
  33. Kroll J, Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun. 1999; 265: 636–639.[CrossRef][Medline] [Order article via Infotrieve]
  34. Kalka C, Masuda H, Takahashi T, et al. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res. 2000; 86: 1198–1202.[Abstract/Free Full Text]
  35. Hariawala MD, Horowitz JR, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 1996; 63: 77–82.[CrossRef][Medline] [Order article via Infotrieve]
  36. Hein TW, Kuo L. LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions. Circ Res. 1998; 83: 404–414.[Abstract/Free Full Text]
  37. Zhang C, Hein TW, Wang W, et al. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J. 2001; 15: 1264–1266.[Free Full Text]
  38. Das R, Kravtsov GM, Ballard HJ, et al. L-NAME inhibits Mg2+-induced rat aortic relaxation in the absence of endothelium. Br J Pharmacol. 1999; 128: 493–499.[CrossRef][Medline] [Order article via Infotrieve]
  39. Banai S, Shweiki D, Pinson A, et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 1994; 28: 1176–1179.[Abstract/Free Full Text]
  40. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359: 843–845.[CrossRef][Medline] [Order article via Infotrieve]
  41. Kanno S, Oda N, Abe M, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene. 2000; 19: 2138–2146.[CrossRef][Medline] [Order article via Infotrieve]
  42. Gielen S, Schuler G, Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation. 2001; 103: e1–e6.[Medline] [Order article via Infotrieve]
  43. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000; 342: 454–460.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. J. Duncker and R. J. Bache
Regulation of Coronary Blood Flow During Exercise
Physiol Rev, July 1, 2008; 88(3): 1009 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Thengchaisri, R. Shipley, Y. Ren, J. Parker, and L. Kuo
Exercise Training Restores Coronary Arteriolar Dilation to NOS Activation Distal to Coronary Artery Occlusion: Role of Hydrogen Peroxide
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 791 - 798.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Lawler, H.-B. Kwak, W. Song, and J. L. Parker
Exercise training reverses downregulation of HSP70 and antioxidant enzymes in porcine skeletal muscle after chronic coronary artery occlusion
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1756 - R1763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. L. Heaps, M. L. Mattox, K. A. Kelly, C. J. Meininger, and J. L. Parker
Exercise training increases basal tone in arterioles distal to chronic coronary occlusion
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1128 - H1135.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Yoshinari, H. Yaoita, K. Maehara, and Y. Maruyama
Different therapeutic responses to treadmill exercise of heart failure due to ischemia and infarction in rats
Cardiovasc Res, February 1, 2005; 65(2): 457 - 468.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fogarty, J. A.
Right arrow Articles by Parker, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogarty, J. A.
Right arrow Articles by Parker, J. L.